Loratadine is a selective inverse agonist of peripheral histamine H1-receptors. Microbial biotransformation gained a lot ofattention for its ability to convert molecules to valuable medicinally active substances. The main objective of the presentresearch was to investigate the ability of different fungi to biotransform the drug loratadine to its active metabolitedesloratadine, because desloratadine is four times more potent, possess longer duration of action than loratadine and iseffective at low doses. The screening studies were performed with selected fungi using their respective broth media andsterile incubation conditions. The drug and metabolites formed (if any) were extracted and analysed using HPLC analysis.Structural elucidation and confirmation of metabolites were by mass and proton NMR spectroscopy. Among the six fungiselected, Cunninghamella elegans, Cunninghamella echinulata and Aspergillus niger cultures showed extra peaks at 3.8,3.6 and 4.1 min, respectively, in HPLC when compared with their controls, which indicated the formation of metabolites.The metabolites thus formed were isolated and their structures were confirmed as dihydroxy desloratadine, desethoxyloratadine and 3-hydroxy desloratadine by Cunninghamella elegans, Cunninghamella echinulata and Aspergillus nigercultures, respectively, by mass spectrometry and NMR spectroscopy. Three fungi were identified to have the ability tobiotransform loratadine to its active metabolite and other different metabolites.
Volume 45, 2020
Continuous Article Publishing mode
Click here for Editorial Note on CAP Mode